SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 14.50
-0.04 (-0.28%)
Jun 12, 2026, 5:29 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 771.6 million as of June 12, 2026. Its market cap has decreased by -17.05% in one year.
Market Cap
771.60M
Enterprise Value
706.89M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
14.50
Market Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 771.60M, an increase of 1,110.32%. That is a compound annual growth rate of 28.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 771.60M | -35.98% |
| Dec 30, 2025 | 1.21B | 189.20% |
| Dec 30, 2024 | 416.76M | 32.69% |
| Dec 29, 2023 | 314.09M | -87.00% |
| Dec 30, 2022 | 2.42B | -34.75% |
| Dec 30, 2021 | 3.70B | 242.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovis AB (publ.) | 1.29B |
| Medivir AB | 930.82M |
| Infant Bacterial Therapeutics AB | 821.76M |
| FluoGuide | 721.00M |
| Xspray Pharma AB | 717.89M |
| Oncopeptides AB | 699.66M |
| Cantargia AB | 537.00M |
| AlzeCure Pharma AB | 491.83M |